Will More Promoters Opt for Exit Route? [India Business]

Extract


Will More Promoters Opt for Exit Route? [India Business]

MUMBAI: For almost two years now, Ranbaxy has been looking at cashing in on some of its drugs. At $4.6 billion, the deal is seen as the firs...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex India

Explore vLex

For Professionals

For Partners

Company